In Th17-cell related inflammatory diseases, including psoriasis and psoriatic arthritis (PsA), dual blocking of IL-17A and IL-17 F has been shown to be more effective than IL-17 A blockade alone43. The gene discussed is IL17A; the disease is psoriasis.